Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
CBC Group redefines CNS care in China with UCB portfolio acquisition
Singapore-based CBC Group, Asia’s largest healthcare-dedicated asset management firm, has finalized its strategic acquisition of UCB’s mature neurology and allergy business in China. In partnership ... Read More
Why Argent BioPharma is leaving the London Stock Exchange—and what it means for investors
Argent BioPharma, a biopharmaceutical company specializing in innovative drug discovery, has announced its decision to delist from the London Stock Exchange (LSE) as part of ... Read More
Allink Biotherapeutics raises $42m to transform oncology and immunology treatments
Allink Biotherapeutics, a Shanghai-based clinical-stage biotechnology company, has completed a $42 million Series A funding round to accelerate its pipeline of bispecific antibodies and antibody-drug ... Read More
Dev4all partners with Pharmaseed to advance preclinical drug development
Dev4All, a cutting-edge R&D booster powered by 4P-Pharma, has announced a groundbreaking commercial partnership with Pharmaseed, a leading Contract Research Organisation (CRO) with over two ... Read More
Galderma’s nemolizumab sets new standard in prurigo nodularis treatment with OLYMPIA 1 trial success
Galderma’s latest clinical trial has unveiled a significant breakthrough in treating prurigo nodularis, a chronic neuroimmune skin condition characterized by relentless itching and thickened skin ... Read More
Dr Reddy’s launches toripalimab in India as first immuno-oncology drug for nasopharyngeal carcinoma
Dr. Reddy’s Laboratories Ltd. announced a significant milestone in its oncology portfolio with the launch of Toripalimab in India. This innovative immuno-oncology drug is the ... Read More
Applied Therapeutics stock collapses as FDA rejects govorestat for galactosemia treatment
Shares of Applied Therapeutics, Inc. (Nasdaq: APLT) suffered a dramatic decline after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) ... Read More
BeiGene stock surges on EU approval for TEVIMBRA in advanced cancer treatment
BeiGene, a global oncology company, announced that the European Commission has granted regulatory approval for TEVIMBRA (tislelizumab), its PD-1 monoclonal antibody, for the first-line treatment ... Read More
Glenmark Pharmaceuticals expands ophthalmic portfolio with new Travoprost Ophthalmic Solution
In a significant move to bolster its position in the United States generics market, Glenmark Pharmaceuticals Inc., USA has launched Travoprost Ophthalmic Solution USP, 0.004% ... Read More
Oxford Nanopore and UK Biobank to pioneer future of personalised medicine
In a major breakthrough for biomedical research, Oxford Nanopore Technologies and UK Biobank have announced a landmark collaboration to create the world’s first large-scale epigenetic ... Read More